[Pharmacological and clinical profile of Darnavir (Prezista)].
Iwata
Michiko
M
Yoshida
Shinya
S
Harada
Yasushi
Y
D017326:Clinical Trials, Phase III as Topic; D000069454:Darunavir; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D015497:HIV-1 / Q000254:growth & development; D006801:Humans; D013449:Sulfonamides / Q000008:administration & dosage / Q000494:pharmacology
D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D000069454:Darunavir